327 filings
Page 8 of 17
8-K
xhzkq rrdxu16n
24 Feb 16
ZIOPHARM Announces First Patient Treated in the Dose Escalation Portion
12:00am
8-K
ld092gxi0e106 jah91h
24 Feb 16
Results of Operations and Financial Condition
12:00am
8-K
l81d3h
11 Jan 16
ZIOPHARM 34th Annual J.P. Morgan Healthcare Conference January 2016 ZIOPHARM Oncology
12:00am
8-K
zxvwwof9j7 pq3r
16 Dec 15
Regulation FD Disclosure
12:00am
8-K
zn8sjng6s lnkp239fi
10 Dec 15
ZIOPHARM Announces Presentation of Phase 1b/2 Study of Ad-RTS-hIL-12
12:00am
8-K
wpg2v
7 Dec 15
ZIOPHARM Announces Presentation of Data from CD19-Specific CAR+ T-Cell Therapy Programs at ASH Annual Meeting
12:00am
8-K
hanik 1de
19 Nov 15
ZIOPHARM Announces Data Highlighting
12:00am
8-K
loa3 aww5no6
12 Nov 15
Regulation FD Disclosure
12:00am
8-K
ntqlqdqrau gad6m57d7
2 Nov 15
ZIOPHARM Reports Third-Quarter 2015 Financial Results and Recent Activities
12:00am
8-K
4ey15iirb4eylrnvk
1 Oct 15
Entry into a Material Definitive Agreement
12:00am
8-K
c4bwm
28 Sep 15
Regulation FD Disclosure
12:00am
8-K
grge6aohfjqcty0
28 Sep 15
ZIOPHARM Appoints Scott Tarriff to Its Board of Directors
12:00am
8-K
flvorl i57y93vet
10 Sep 15
This presentation contains certain forward-looking information about ZIOPHARM Oncology, Inc. that is intended to be
12:00am
8-K
xykdaie lioeenim
21 Aug 15
Entry into a Material Definitive Agreement
12:00am
8-K
5dmdrixk9 zbqakk
10 Aug 15
ZIOPHARM Reports Second-Quarter 2015 Financial Results and Recent Activities
12:00am
8-K
m0bxch42o
19 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
2lq gvwtw
18 Jun 15
Regulation FD Disclosure
12:00am
8-K/A
yofsnghzuzfg1 8n
8 Jun 15
Entry into a Material Definitive Agreement
12:00am
8-K
fofwqwv4i7tg1h6
2 Jun 15
Appointed Chief Operating Officer
12:00am
8-K
3v6e3tw7hgxx7l
15 May 15
Departure of Directors or Certain Officers
12:00am